BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6574961)

  • 1. Natural killer cells and their targets: impact of differentiation on target cell susceptibility.
    Gidlund M; Nilsson K; Tötterman T; Wigzell H
    Haematol Blood Transfus; 1983; 28():466-9. PubMed ID: 6574961
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of natural cytotoxicity by alloantibodies. V. The mechanism of a selective augmenting effect of anti-H-2 antisera on the natural killer activity of mouse spleen cells.
    Saxena RK; Saxena QB; Adler WH
    Cell Immunol; 1981 Nov; 65(1):115-30. PubMed ID: 6797740
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequency determination of killer cells by a single-cell cytotoxic assay.
    Bonavida B; Bradley TP; Grimm EA
    Methods Enzymol; 1983; 93():270-80. PubMed ID: 6408349
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor cell differentiation modulates susceptibility to natural killer cells.
    Werkmeister J; Helfand SL; Haliotis T; Rubin P; Pross H; Roder J
    Cell Immunol; 1982 May; 69(1):122-7. PubMed ID: 6955028
    [No Abstract]   [Full Text] [Related]  

  • 5. A search for target cell structures associated with susceptibility to NK cells.
    Henney CS
    Adv Exp Med Biol; 1982; 146():357-66. PubMed ID: 7102463
    [No Abstract]   [Full Text] [Related]  

  • 6. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.
    Rees RC; Reynolds CW; Herberman RB
    Cancer Res; 1983 Sep; 43(9):4248-52. PubMed ID: 6871862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells mediate lysis of embryonal carcinoma cells lacking MHC.
    Stern P; Gidlund M; Orn A; Wigzell H
    Nature; 1980 May; 285(5763):341-2. PubMed ID: 7374786
    [No Abstract]   [Full Text] [Related]  

  • 8. Natural killer cells kill tumour cells at a given stage of differentiation.
    Gidlund M; Orn A; Pattengale PK; Jansson M; Wigzell H; Nilsson K
    Nature; 1981 Aug; 292(5826):848-50. PubMed ID: 7266653
    [No Abstract]   [Full Text] [Related]  

  • 9. Some studies on natural killer cells in man.
    Lotzová E; McCredie KB; Maroun JA; Dicke KA; Freireich EJ
    Transplant Proc; 1979 Jun; 11(2):1390-2. PubMed ID: 314185
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental application of a multistep kinetic model for natural cytotoxicity: determination of rate constants for lytic programming and killer-cell-independent lysis.
    Callewaert DM; Mahle NH; Genyea J; Wilusz JR; Chores JB; Baker S; Thomas R; Ruedisueli E
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):210-21. PubMed ID: 6597342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of natural killer activity in the resistance of allogeneic hosts to the embryonal carcinoma cell line F9.
    Simmler MC; Avner PR
    Am J Reprod Immunol (1980); 1982 Dec; 2(6):301-8. PubMed ID: 7158680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology of natural killer cells.
    Trinchieri G
    Adv Immunol; 1989; 47():187-376. PubMed ID: 2683611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune status of leukemia patients.
    Kaneko Y; Miyakoshi H; Aoyagi Y; Aoki T
    Haematol Blood Transfus; 1985; 29():200-3. PubMed ID: 3861482
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon.
    Zarling JM; Eskra L; Borden EC; Horoszewicz J; Carter WA
    J Immunol; 1979 Jul; 123(1):63-70. PubMed ID: 286738
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural cytotoxicity to human leukemia mediated by mouse non-T cells.
    Haller O; Kiessling R; Orn A; Kärre K; Nilsson K; Wigzell H
    Int J Cancer; 1977 Jul; 20(1):93-103. PubMed ID: 903185
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune properties of human teratocarcinoma. I. Human teratocarcinoma targets distinguish between natural killer and activated killer cells.
    Carroll PG; DeWolf WC
    J Immunol; 1983 Aug; 131(2):1007-10. PubMed ID: 6863924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural cellular defense activities against tumors--cytostasis and NK activity.
    Ehrlich R; Efrati M; Gonen B; Shochat L; Witz IP
    Haematol Blood Transfus; 1983; 28():470-1. PubMed ID: 6862310
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro sensitization of human lymphocytes against allogeneic cells by antigen-fed macrophages.
    Treves AJ; Heidelberger E; Feldman M; Kaplan HS
    Isr J Med Sci; 1979 Jul; 15(7):564-9. PubMed ID: 478818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of primitive cells by natural killer cells.
    Kiessling R; Wigzell H
    Curr Top Microbiol Immunol; 1981; 92():107-23. PubMed ID: 6171383
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural killer cells in resistance to virus-infected cells.
    Rager-Zisman B; Bloom BR
    Springer Semin Immunopathol; 1982; 4(4):397-414. PubMed ID: 6183763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.